Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pediatrix Medical (MD) Assets (2016 - 2025)

Historic Assets for Pediatrix Medical (MD) over the last 17 years, with Q3 2025 value amounting to $2.2 billion.

  • Pediatrix Medical's Assets rose 589.98% to $2.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 billion, marking a year-over-year increase of 589.98%. This contributed to the annual value of $2.2 billion for FY2024, which is 302.32% down from last year.
  • As of Q3 2025, Pediatrix Medical's Assets stood at $2.2 billion, which was up 589.98% from $2.1 billion recorded in Q2 2025.
  • Over the past 5 years, Pediatrix Medical's Assets peaked at $2.7 billion during Q4 2021, and registered a low of $2.0 billion during Q1 2025.
  • Over the past 5 years, Pediatrix Medical's median Assets value was $2.3 billion (recorded in 2023), while the average stood at $2.3 billion.
  • Its Assets has fluctuated over the past 5 years, first tumbled by 4250.14% in 2021, then surged by 589.98% in 2025.
  • Pediatrix Medical's Assets (Quarter) stood at $2.7 billion in 2021, then fell by 13.76% to $2.3 billion in 2022, then dropped by 5.45% to $2.2 billion in 2023, then fell by 3.02% to $2.2 billion in 2024, then increased by 2.17% to $2.2 billion in 2025.
  • Its Assets was $2.2 billion in Q3 2025, compared to $2.1 billion in Q2 2025 and $2.0 billion in Q1 2025.